Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study. [electronic resource]
Producer: 20190923Description: 1213-1214 p. digitalISSN:- 1365-2133
- Antineoplastic Agents -- administration & dosage
- Drug Administration Schedule
- Hemangioendothelioma -- drug therapy
- Humans
- Infant
- Kasabach-Merritt Syndrome -- drug therapy
- Retrospective Studies
- Sarcoma, Kaposi -- drug therapy
- Sirolimus -- administration & dosage
- Treatment Outcome
- Vascular Neoplasms -- drug therapy
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.